Fig. 1From: Foot-ankle functional outcomes of using the Diabetic Foot Guidance System (SOPeD) for people with diabetic neuropathy: a feasibility study for the single-blind randomized controlled FOotCAre (FOCA) trial IFlowchart of the feasibility study explaining reasons for inclusion and exclusion. T12—evaluation at 12 weeks, DM—diabetes mellitus, DPN—diabetic peripheral neuropathy, SOPeD—Diabetic Foot Guidance SystemBack to article page